Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

The effect of costimulatory and interleukin 2 receptor blockade on regulatory T cells in renal transplantation.

Bluestone JA, Liu W, Yabu JM, Laszik ZG, Putnam A, Belingheri M, Gross DM, Townsend RM, Vincenti F.

Am J Transplant. 2008 Oct;8(10):2086-96. doi: 10.1111/j.1600-6143.2008.02377.x.

2.

Absence of CD4CD25 regulatory T cell expansion in renal transplanted patients treated in vivo with Belatacept mediated CD28-CD80/86 blockade.

Chavez H, Beaudreuil S, Abbed K, Taoufic Y, Kriaa F, Charpentier B, Durrbach A.

Transpl Immunol. 2007 Jun;17(4):243-8. Epub 2007 Jan 24.

PMID:
17493526
3.

T-cell phenotype in protocol renal biopsy from transplant recipients treated with belatacept-mediated co-stimulatory blockade.

Grimbert P, Audard V, Diet C, Matignon M, Plonquet A, Mansour H, Desvaux D, Durrbach A, Cohen JL, Lang P.

Nephrol Dial Transplant. 2011 Mar;26(3):1087-93. doi: 10.1093/ndt/gfq453. Epub 2010 Jul 28.

PMID:
20667993
4.

[Regulatory T cells in kidney transplant recipients].

Libetta C, Portalupi V, Margiotta E, Sepe V, Canevari M, Meloni F, Morosini M, Dal Canton A.

G Ital Nefrol. 2009 Mar-Apr;26 Suppl 45:S54-7. Italian.

PMID:
19382095
5.

Short-term anti-CD25 monoclonal antibody administration down-regulated CD25 expression without eliminating the neogenetic functional regulatory T cells in kidney transplantation.

Wang Z, Shi BY, Qian YY, Cai M, Wang Q.

Clin Exp Immunol. 2009 Mar;155(3):496-503. doi: 10.1111/j.1365-2249.2008.03847.x. Epub 2009 Jan 7.

6.

Impact of Basiliximab on regulatory T-cells early after kidney transplantation: down-regulation of CD25 by receptor modulation.

Vondran FW, Timrott K, Tross J, Kollrich S, Schwarz A, Lehner F, Klempnauer J, Becker T, Schwinzer R.

Transpl Int. 2010 May 1;23(5):514-23. doi: 10.1111/j.1432-2277.2009.01013.x. Epub 2009 Nov 30.

7.

High levels of IDO-expressing CD16+ peripheral cells, and Tregs in graft biopsies from kidney transplant recipients under belatacept treatment.

Furuzawa-Carballeda J, Lima G, Uribe-Uribe N, Avila-Casado C, Mancilla E, Morales-Buenrostro LE, Pérez-Garrido J, Pérez M, Cárdenas G, Llorente L, Alberú J.

Transplant Proc. 2010 Nov;42(9):3489-96. doi: 10.1016/j.transproceed.2010.08.037.

PMID:
21094802
8.

CD25 appears non essential for human peripheral T(reg) maintenance in vivo.

de Goër de Herve MG, Gonzales E, Hendel-Chavez H, Décline JL, Mourier O, Abbed K, Jacquemin E, Taoufik Y.

PLoS One. 2010 Jul 30;5(7):e11784. doi: 10.1371/journal.pone.0011784.

9.

Regulatory T cells in kidney transplant recipients: the effect of induction immunosuppression therapy.

Krystufkova E, Sekerkova A, Striz I, Brabcova I, Girmanova E, Viklicky O.

Nephrol Dial Transplant. 2012 Jun;27(6):2576-82. doi: 10.1093/ndt/gfr693. Epub 2011 Dec 13.

PMID:
22167587
10.

Short-term anti-CD25 monoclonal antibody treatment and neogenetic CD4(+)CD25(high) regulatory T cells in kidney transplantation.

Wang Z, Xiao L, Shi BY, Qian YY, Bai HW, Chang JY, Cai M.

Transpl Immunol. 2008 Apr;19(1):69-73. doi: 10.1016/j.trim.2008.01.005. Epub 2008 Feb 22.

PMID:
18346640
11.

CD25 blockade in kidney transplant patients randomized to standard-dose or high-dose basiliximab with cyclosporine, or high-dose basiliximab in a calcineurin inhibitor-free regimen.

Thibault G, Paintaud G, Legendre C, Merville P, Coulon M, Chasseuil E, Ternant D, Rostaing L, Durrbach A, Di Giambattista F, Büchler M, Lebranchu Y.

Transpl Int. 2016 Feb;29(2):184-95. doi: 10.1111/tri.12688. Epub 2015 Oct 8.

12.

Oscillatory mTOR inhibition and Treg increase in kidney transplantation.

Sabbatini M, Ruggiero G, Palatucci AT, Rubino V, Federico S, Giovazzino A, Apicella L, Santopaolo M, Matarese G, Galgani M, Terrazzano G.

Clin Exp Immunol. 2015 Nov;182(2):230-40. doi: 10.1111/cei.12669. Epub 2015 Aug 28.

13.

Infiltrating cellular pattern in kidney graft biopsies translates into forkhead box protein 3 up-regulation and p16INK4α senescence protein down-regulation in patients treated with belatacept compared to cyclosporin A.

Furuzawa-Carballeda J, Lima G, Alberú J, Palafox D, Uribe-Uribe N, Morales-Buenrostro LE, Reyes Acevedo R, Mondragón G, Chevaile A, Llorente L.

Clin Exp Immunol. 2012 Feb;167(2):330-7. doi: 10.1111/j.1365-2249.2011.04504.x.

14.

CD4+ CD25+ FOXP3+ regulatory T cells increase de novo in kidney transplant patients after immunodepletion with Campath-1H.

Bloom DD, Chang Z, Fechner JH, Dar W, Polster SP, Pascual J, Turka LA, Knechtle SJ.

Am J Transplant. 2008 Apr;8(4):793-802. doi: 10.1111/j.1600-6143.2007.02134.x. Epub 2008 Feb 5.

15.

Sirolimus did not affect CD4(+)CD25(high) forkhead box p3(+)T cells of peripheral blood in renal transplant recipients.

Chu ZQ, Ji Q.

Transplant Proc. 2013 Jan-Feb;45(1):153-6. doi: 10.1016/j.transproceed.2012.07.145.

PMID:
23375290
16.

Belatacept.

Vincenti F, Dritselis A, Kirkpatrick P.

Nat Rev Drug Discov. 2011 Aug 31;10(9):655-6. doi: 10.1038/nrd3536. No abstract available.

PMID:
21878974
17.

Impact of basiliximab on the proportion of regulatory T cells and their subsets early after renal transplantation: a preliminary report.

Zhao T, Yang C, Xue Y, Qiu YY, Hu L, Qiu Y, Wang X, Yang B, Rong R, Xu M, Zhu T.

Transplant Proc. 2012 Jan;44(1):175-8. doi: 10.1016/j.transproceed.2011.11.026.

PMID:
22310608
18.

Decreased frequency of peripheral CD4(+) CD161(+) Th(17) -precursor cells in kidney transplant recipients on long-term therapy with Belatacept.

Vondran FW, Timrott K, Kollrich S, Klempnauer J, Schwinzer R, Becker T.

Transpl Int. 2012 Apr;25(4):455-63. doi: 10.1111/j.1432-2277.2012.01441.x. Epub 2012 Feb 20. Erratum in: Transpl Int. 2012 Oct;25(10):1117.

19.

FOXP3+ regulatory T cells: from suppression of rejection to induction of renal allograft tolerance.

Dummer CD, Carpio VN, Gonçalves LF, Manfro RC, Veronese FV.

Transpl Immunol. 2012 Jan;26(1):1-10. doi: 10.1016/j.trim.2011.08.009. Epub 2011 Sep 13. Review.

PMID:
21939765
20.

FOXP3 induced by CD28/B7 interaction regulates CD25 and anergic phenotype in human CD4+CD25- T lymphocytes.

Scottà C, Soligo M, Camperio C, Piccolella E.

J Immunol. 2008 Jul 15;181(2):1025-33.

Supplemental Content

Support Center